FDA claims Med-Pharmex failed to conform to current good manufacturing practices. in a recent article posted to Veterinary Practice New, Med-pharmex is involved in a FDA investigation. This is most likely going to contribute to future shortages of these products,…
The U.S. Food and Drug Administration (FDA) has approved ProHeart® 12 (moxidectin), the new, first-ever once-yearly injection to prevent heartworm disease (caused by Dirofilaria immitis) in dogs 12 months of age and older. Its unique formulation of moxidectin microspheres provides…
According to AAHA NEWStat, the US Food and Drug Administration (FDA) announced recently that it had approved ProZinc for the treatment of hyperglycemia and clinical signs associated with hyperglycemia in dogs with diabetes mellitus (DM). ProZinc (protamine zinc recombinant human insulin) is manufactured by Boehringer Ingelheim…